Markus Matilainen
PhD
Turku PET Centre manmat@utu.fi +358 29 450 4739 +358 50 472 8469 Itäinen Pitkäkatu 4 Turku ORCID identifier: https://orcid.org/0000-0002-5597-2670 |
Areas of expertise
Statistics; Biostatistics; Blind Source Separation
Statistics; Biostatistics; Blind Source Separation
Publications 
1 of 3
- Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (2024)
- EJNMMI Research
(Refereed journal article or data article (A1)) - Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)
- Frontiers in Neurology
(Refereed journal article or data article (A1)) - Stationary subspace analysis based on second-order statistics (2024)
- Journal of Computational and Applied Mathematics
(Refereed journal article or data article (A1)) - Adenosine A2A receptor availability in cerebral gray and white matter of patients with Parkinson's disease (2023)
- Parkinsonism and Related Disorders
(Refereed journal article or data article (A1)) - Akillesjännerepeämien maantieteelliset erot esiintyvyydessä ja hoitomuodoissa Suomessa vuosina 1997-2019 – maanlaajuinen tutkimus (2023)
- Suomen ortopedia ja traumatologia
(Article in trade journal or blog post (D1)) - Association of serum neurofilament light with microglial activation in multiple sclerosis (2023)
- Journal of Neurology, Neurosurgery and Psychiatry
(Refereed journal article or data article (A1)) - Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis (2023)
- Multiple Sclerosis and Related Disorders
(Refereed journal article or data article (A1)) - Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis (2023)
- European Journal of Neurology
(Refereed journal article or data article (A1)) - Olkaluun yläosan murtumien ilmaantuvuuden ja hoitomenetelmien alueelliset erot Suomessa 1997-2019 (2023)
- Suomen ortopedia ja traumatologia
(Article in trade journal or blog post (D1)) - PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report (2023)
- Journal of Neurology
(Article or data-article in scientific journal (B1)) - TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis (2023)
- Neurology, Neuroimmunology and Neuroinflammation
(Refereed journal article or data article (A1)) - A review of second-order blind identification methods (2022)
- Wiley Interdisciplinary Reviews: Computational Statistics
(Refereed review article in scientific journal (A2)) - Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients (2022)
- Multiple Sclerosis and Related Disorders
(Refereed journal article or data article (A1)) - Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation (2022)
- EJNMMI Research
(Refereed journal article or data article (A1)) - Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis (2022)
- Neurology, Neuroimmunology and Neuroinflammation
(Refereed journal article or data article (A1)) - No difference in implant survival between 28-mm M2a RingLoc metal-on-metal and metal-on-polyethylene total hip arthroplasty: results from the Finnish Arthroplasty Register (2022)
- Acta Orthopaedica
(Refereed journal article or data article (A1)) - Phenotyping of multiple sclerosis lesions according to innate immune cell activation using TSPO-PET (2022)
- Brain Communications
(Refereed journal article or data article (A1)) - Dimension Reduction for Time Series in a Blind Source Separation Context Using R (2021)
- Journal of Statistical Software
(Refereed journal article or data article (A1)) - Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's disease (2021)
- Parkinsonism and Related Disorders
(Refereed journal article or data article (A1)) - Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study (2021)
- Multiple Sclerosis and Related Disorders
(Refereed journal article or data article (A1))
UTU Research Portal